054050 — Nong Woo Bio Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesConservativeSmall CapContrarian

Annual income statement for Nong Woo Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	130,030	132,843	133,400	135,844	144,680
Cost of Revenue
Gross Profit	59,741	63,203	65,593	66,181	71,886
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	125,997	127,163	123,510	127,673	134,156
Operating Profit	4,033	5,680	9,890	8,171	10,524
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	7,770	7,581	10,812	9,980	13,466
Provision for Income Taxes
Net Income After Taxes	9,456	6,953	9,886	10,169	10,909
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	9,400	6,930	9,879	10,333	10,839
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	9,400	6,930	9,879	10,333	10,839
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	584	494	661	625	694
Dividends per Share